CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Shionogi's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
Feb 17, 2021Pharmaceutical Composition For Cancer Treatment10
Dec 9, 2020Hiv Replication Inhibitor1
Jan 1, 2020Medicinal Composition For Treating Cancer5
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
Mar 15, 2017Antiviral Agent1

Top competitors of Shionogi

Top competitors of Shionogi based on patent oppositions.